# Wim Hof Method and Lifestyle Changes Reduce Inflammation in MS > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/wim-hof-method-inflammation-ms-study/ > **Published:** 2026-04-07T21:03:17-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:27:59-04:00 > **Clinical Summary:** Explore how the Wim Hof method inflammation MS study reveals lifestyle changes that reduce inflammation in multiple sclerosis patients. --- ✦ New CED Clinical Relevance  #80High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic Multiple SclerosisInflammationMind-Body MedicineComplementary MedicineAutoimmune Why This Matters Multiple sclerosis patients frequently seek complementary approaches to manage inflammation and symptoms, making evidence-based evaluation of interventions like the Wim Hof method clinically relevant. Understanding which lifestyle modifications demonstrate measurable [anti-inflammatory effects](https://cedclinic.com/cbd-antioxidative-anti-inflammatory-properties-benefits/) can inform comprehensive MS care strategies. Clinical Summary A study examined the Wim Hof method — combining cold exposure, breathing techniques, and meditation — in MS patients, finding reduced inflammatory markers compared to controls. The intervention appears to modulate immune system activity, potentially through autonomic nervous system pathways that influence inflammatory cytokine production. While the inflammatory reduction is measurable, the clinical significance for MS disease progression or symptom management remains unclear from this preliminary research. Dr. Caplan’s Take “This adds to growing evidence that structured mind-body interventions can produce measurable physiological changes, but we’re still connecting dots between biomarker improvements and meaningful clinical outcomes for MS patients. I counsel patients that such approaches may be beneficial additions to conventional care, not replacements.” Clinical Perspective 🧠 Patients interested in the Wim Hof method should view it as a potential complementary approach requiring gradual introduction and medical oversight, particularly given cold exposure risks. Clinicians should monitor for any changes in MS symptoms or medication needs when patients adopt intensive lifestyle interventions. The inflammatory marker improvements are encouraging but don’t yet translate to established disease-modifying benefits. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Wim%20Hof%20method%2C%20lifestyle%20changes%20reduce%20inflammation%20in%20new%20MS%20study%20%40drcaplan&url=https%3A//multiplesclerosisnewstoday.com/news-posts/2026/04/07/wim-hof-lifestyle-program-reduce-inflammation-ms/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//multiplesclerosisnewstoday.com/news-posts/2026/04/07/wim-hof-lifestyle-program-reduce-inflammation-ms/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Wim%20Hof%20method%2C%20lifestyle%20changes%20reduce%20inflammation%20in%20new%20MS%20study%20--%20via%20%40drcaplan.bsky.social%20https%3A//multiplesclerosisnewstoday.com/news-posts/2026/04/07/wim-hof-lifestyle-program-reduce-inflammation-ms/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://multiplesclerosisnewstoday.com/news-posts/2026/04/07/wim-hof-lifestyle-program-reduce-inflammation-ms/](https://multiplesclerosisnewstoday.com/news-posts/2026/04/07/wim-hof-lifestyle-program-reduce-inflammation-ms/) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis research?](#What_is_the_clinical_relevance_rating_of_this_cannabis_research) - [What medical conditions does this cannabis news relate to?](#What_medical_conditions_does_this_cannabis_news_relate_to) - [Is this information from a clinical source?](#Is_this_information_from_a_clinical_source) - [What type of medical approach does this represent?](#What_type_of_medical_approach_does_this_represent) - [How does this relate to inflammation treatment?](#How_does_this_relate_to_inflammation_treatment) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis research? This research has received a “High Clinical Relevance” rating (#80) from CED. This indicates strong evidence or policy relevance with direct clinical implications for patient care. #### What medical conditions does this cannabis news relate to? The research focuses primarily on Multiple Sclerosis treatment. It also addresses inflammation management and falls under complementary and mind-body medicine approaches. #### Is this information from a clinical source? Yes, this news comes from CED Clinic, which appears to be a [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) organization. The high clinical relevance rating suggests this information is intended for healthcare professionals. #### What type of medical approach does this represent? This represents complementary and mind-body medicine approaches to treating Multiple Sclerosis. It focuses on using cannabis as an alternative or adjunctive treatment for neurological conditions. #### How does this relate to inflammation treatment? The research appears to examine cannabis’s anti-inflammatory properties in the context of Multiple Sclerosis. This suggests the study may focus on how [cannabis compounds](https://cedclinic.com/cannabis-terpene-synergy-entourage-effect/) can help manage the inflammatory processes associated with MS. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [The Best CBD for Immune Support and Daily Resilience in 2026](https://cedclinic.com/the-best-cbd-for-immune-support-and-daily-resilience-in-2026-stupiddope-est-2008/) Discover top CBD options that support immune health and resilience, complementing lifestyle approaches like the Wim Hof method. [Learn More](https://cedclinic.com/the-best-cbd-for-immune-support-and-daily-resilience-in-2026-stupiddope-est-2008/) [The Best CBD for Mental Clarity and Focus in 2026](https://cedclinic.com/best-cbd-for-mental-clarity-2026-focus-stupiddope/) Explore [CBD products](https://cedclinic.com/fda-warning-on-cbd-products/) that enhance mental clarity and focus, beneficial for managing symptoms in neurological conditions. [Explore Now](https://cedclinic.com/best-cbd-for-mental-clarity-2026-focus-stupiddope/) [Study Reveals Cannabis Compounds Reduce Threat of Fatty Liver Disease](https://cedclinic.com/cannabis-compounds-liver-protection-fatty-liver-insights/) Learn about cannabis compounds' [anti-inflammatory effects](https://cedclinic.com/cbd-antioxidative-anti-inflammatory-properties-benefits/) that may complement treatments for autoimmune and [inflammatory diseases](https://cedclinic.com/citral-cannabinoid-receptor-2-activation-pain-relief/). [Read Study](https://cedclinic.com/cannabis-compounds-liver-protection-fatty-liver-insights/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).